If anyone from our congressional delegation has asked you about Tamiflu Pricing and/or if you've heard the OK state AG's office is investigating, I thought the letter IACP sent to US Senator Chris Dodd may be helpful.
Dear Senator Dodd:
On November 18, 2009, you issued a press release requesting that the Secretary of Health and Human Services and the U.S. Attorney General investigate perceived price gouging by some pharmacies that provide compounded Tamiflu suspension for children. On behalf of the membership of the International Academy of Compounding Pharmacists (IACP), the national organization representing providers of personalized medication solutions, I can assure you that we do not condone the alleged activity you suggest is occurring. While IACP does not engage in the marketplace or pricing methodologies, perhaps we can provide some insight that will help you and your staff better understand this unique and important component of pharmacy practice. Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment